Rosenblatt Maintains Buy on Xometry, Raises Price Target to $120

Benzinga Newsdesk www.benzinga.com Positive 66.4%

Neg 0% Neu 0% Pos 66.4%

Rosenblatt analyst Scott Devitt maintains Xometry (NASDAQ:XMTR) with a Buy and raises the price target from $110 to $120.